Skip to main content
Top
Published in: Diabetologia 11/2009

01-11-2009 | Article

Increased susceptibility to oxidative damage in post-diabetic human myotubes

Authors: S. R. Costford, S. A. Crawford, R. Dent, R. McPherson, M.-E. Harper

Published in: Diabetologia | Issue 11/2009

Login to get access

Abstract

Aims/hypothesis

Obesity is an important risk factor for the development of type 2 diabetes, but not all obese individuals develop this complication. The clinical signs of type 2 diabetes can often be reversed with weight loss; however, it is unknown whether the skeletal muscle oxidative stress associated with type 2 diabetes remains after weight loss. We hypothesised that chronic exposure to high glucose and insulin would re-elicit impaired metabolism in primary myotubes from patients with a history of type 2 diabetes.

Methods

Obese participants with or without type 2 diabetes completed a standardised weight loss protocol, following which all participants were euglycaemic and had similar indices of insulin sensitivity. Satellite cells were isolated from muscle biopsies and differentiated under low or high glucose and insulin conditions (HGI).

Results

Cells from participants with no history of type 2 diabetes showed robust increases in mitochondrial content, citrate synthase and cytochrome c oxidase activities when exposed to HGI. This increase in oxidative capacity was absent in cells from patients with a history of type 2 diabetes. High glucose and insulin caused increased oxidative damage in cells from the latter, despite higher superoxide dismutase expression. Cells from patients with a history of type 2 diabetes were unable to decrease mitochondrial membrane potential in response to HGI, potentially due to lower levels of uncoupling protein-3.

Conclusions/interpretation

This is the first report to note that primary myotubes from patients with a history of type 2 diabetes are unable to adapt to a hyperglycaemic–hyperinsulinaemic challenge. We have demonstrated that impaired mitochondrial biogenesis and an inability to manage oxidative stress define a muscle phenotype at risk of obesity-associated type 2 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed
2.
go back to reference Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med 45:348–352CrossRefPubMed Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med 45:348–352CrossRefPubMed
3.
go back to reference Gregg EW, Cheng YJ, Cadwell BL et al (2005) Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293:1868–1874CrossRefPubMed Gregg EW, Cheng YJ, Cadwell BL et al (2005) Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293:1868–1874CrossRefPubMed
4.
go back to reference Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662CrossRefPubMed Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662CrossRefPubMed
5.
go back to reference Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA (1985) Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357–364CrossRefPubMed Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA (1985) Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357–364CrossRefPubMed
6.
go back to reference Phillips DI, Caddy S, Ilic V et al (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45:947–950CrossRefPubMed Phillips DI, Caddy S, Ilic V et al (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45:947–950CrossRefPubMed
7.
go back to reference Perseghin G, Scifo P, De Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606CrossRefPubMed Perseghin G, Scifo P, De Cobelli F et al (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H–13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600–1606CrossRefPubMed
8.
go back to reference Krssak M, Falk Petersen K, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116CrossRefPubMed Krssak M, Falk Petersen K, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116CrossRefPubMed
9.
go back to reference van Loon LJ, Goodpaster BH (2006) Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451:606–616CrossRefPubMed van Loon LJ, Goodpaster BH (2006) Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451:606–616CrossRefPubMed
10.
go back to reference Koves TR, Ussher JR, Noland RC et al (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45–56CrossRefPubMed Koves TR, Ussher JR, Noland RC et al (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45–56CrossRefPubMed
11.
go back to reference Hegarty BD, Cooney GJ, Kraegen EW, Furler SM (2002) Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51:1477–1484CrossRefPubMed Hegarty BD, Cooney GJ, Kraegen EW, Furler SM (2002) Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51:1477–1484CrossRefPubMed
12.
go back to reference Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed
13.
go back to reference Kelley DE, Goodpaster BH, Storlien L (2002) Muscle triglyceride and insulin resistance. Annu Rev Nutr 22:325–346CrossRefPubMed Kelley DE, Goodpaster BH, Storlien L (2002) Muscle triglyceride and insulin resistance. Annu Rev Nutr 22:325–346CrossRefPubMed
14.
go back to reference Ravussin E, Smith SR (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363–378PubMedCrossRef Ravussin E, Smith SR (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363–378PubMedCrossRef
15.
16.
go back to reference Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471CrossRefPubMed Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466–8471CrossRefPubMed
17.
go back to reference Morino K, Petersen KF, Dufour S et al (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587–3593CrossRefPubMed Morino K, Petersen KF, Dufour S et al (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587–3593CrossRefPubMed
18.
go back to reference Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950CrossRefPubMed Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950CrossRefPubMed
19.
go back to reference Toledo FG, Menshikova EV, Ritov VB et al (2007) Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56:2142–2147CrossRefPubMed Toledo FG, Menshikova EV, Ritov VB et al (2007) Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56:2142–2147CrossRefPubMed
20.
go back to reference Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, Kelley DE (2005) Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288:E818–825CrossRefPubMed Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, Kelley DE (2005) Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288:E818–825CrossRefPubMed
21.
go back to reference Eriksson JW (2007) Metabolic stress in insulin's target cells leads to ROS accumulation – a hypothetical common pathway causing insulin resistance. FEBS Lett 581:3734–3742CrossRefPubMed Eriksson JW (2007) Metabolic stress in insulin's target cells leads to ROS accumulation – a hypothetical common pathway causing insulin resistance. FEBS Lett 581:3734–3742CrossRefPubMed
22.
go back to reference Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84–92CrossRefPubMed Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84–92CrossRefPubMed
23.
go back to reference Civitarese AE, Ravussin E (2008) Mitochondrial energetics and insulin resistance. Endocrinology 149:950–954CrossRefPubMed Civitarese AE, Ravussin E (2008) Mitochondrial energetics and insulin resistance. Endocrinology 149:950–954CrossRefPubMed
24.
go back to reference Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622CrossRefPubMed Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622CrossRefPubMed
25.
go back to reference Evans JL, Maddux BA, Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7:1040–1052CrossRefPubMed Evans JL, Maddux BA, Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7:1040–1052CrossRefPubMed
26.
go back to reference Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944–948CrossRefPubMed Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944–948CrossRefPubMed
27.
go back to reference Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1–8CrossRefPubMed Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1–8CrossRefPubMed
28.
go back to reference Anderson EJ, Lustig ME, Boyle KE et al (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119:573–581 Anderson EJ, Lustig ME, Boyle KE et al (2009) Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119:573–581
29.
go back to reference Chung SS, Kim M, Youn BS et al (2009) Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Mol Cell Biol 29:20–30CrossRefPubMed Chung SS, Kim M, Youn BS et al (2009) Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Mol Cell Biol 29:20–30CrossRefPubMed
30.
go back to reference Wilson PW, Paffenbarger RS Jr, Morris JN, Havlik RJ (1986) Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J 111:1177–1192CrossRefPubMed Wilson PW, Paffenbarger RS Jr, Morris JN, Havlik RJ (1986) Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J 111:1177–1192CrossRefPubMed
31.
go back to reference Dent RM, Penwarden RM, Harris N, Hotz SB (2002) Development and evaluation of patient-centered software for a weight-management clinic. Obes Res 10:651–656CrossRefPubMed Dent RM, Penwarden RM, Harris N, Hotz SB (2002) Development and evaluation of patient-centered software for a weight-management clinic. Obes Res 10:651–656CrossRefPubMed
32.
go back to reference Ahituv N, Kavaslar N, Schackwitz W et al (2007) Medical sequencing at the extremes of human body mass. Am J Hum Genet 80:779–791CrossRefPubMed Ahituv N, Kavaslar N, Schackwitz W et al (2007) Medical sequencing at the extremes of human body mass. Am J Hum Genet 80:779–791CrossRefPubMed
33.
go back to reference DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
35.
go back to reference Scaduto RC Jr, Grotyohann LW (1999) Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76:469–477CrossRefPubMed Scaduto RC Jr, Grotyohann LW (1999) Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76:469–477CrossRefPubMed
36.
go back to reference Association AD (2008) Standards of medical care in diabetes—2008. Diabetes Care 31(Suppl 1):S12–S54CrossRef Association AD (2008) Standards of medical care in diabetes—2008. Diabetes Care 31(Suppl 1):S12–S54CrossRef
37.
go back to reference Echtay KS, Roussel D, St-Pierre J et al (2002) Superoxide activates mitochondrial uncoupling proteins. Nature 415:96–99CrossRefPubMed Echtay KS, Roussel D, St-Pierre J et al (2002) Superoxide activates mitochondrial uncoupling proteins. Nature 415:96–99CrossRefPubMed
38.
go back to reference Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD (2002) Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277:47129–47135CrossRefPubMed Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD (2002) Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277:47129–47135CrossRefPubMed
39.
go back to reference Echtay KS, Esteves TC, Pakay JL et al (2003) A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22:4103–4110CrossRefPubMed Echtay KS, Esteves TC, Pakay JL et al (2003) A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22:4103–4110CrossRefPubMed
40.
go back to reference Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M (1993) Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1287–1293CrossRefPubMed Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M (1993) Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1287–1293CrossRefPubMed
41.
go back to reference Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839–847CrossRefPubMed Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839–847CrossRefPubMed
42.
go back to reference He J, Kelley DE (2004) Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 287:E1002–1007CrossRefPubMed He J, Kelley DE (2004) Muscle glycogen content in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 287:E1002–1007CrossRefPubMed
43.
go back to reference Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed Eriksson J, Franssila-Kallunki A, Ekstrand A et al (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337–343PubMed
44.
go back to reference Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142CrossRefPubMed Petersen KF, Befroy D, Dufour S et al (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142CrossRefPubMed
45.
go back to reference Unoki H, Yamagishi S (2008) Advanced glycation end products and insulin resistance. Curr Pharm Des 14:987–989CrossRefPubMed Unoki H, Yamagishi S (2008) Advanced glycation end products and insulin resistance. Curr Pharm Des 14:987–989CrossRefPubMed
46.
go back to reference Schrauwen P, Hesselink MK, Blaak EE et al (2001) Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 50:2870–2873CrossRefPubMed Schrauwen P, Hesselink MK, Blaak EE et al (2001) Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 50:2870–2873CrossRefPubMed
47.
go back to reference Hulver MW, Berggren JR, Cortright RN et al (2003) Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741–E747PubMed Hulver MW, Berggren JR, Cortright RN et al (2003) Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741–E747PubMed
Metadata
Title
Increased susceptibility to oxidative damage in post-diabetic human myotubes
Authors
S. R. Costford
S. A. Crawford
R. Dent
R. McPherson
M.-E. Harper
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1480-y

Other articles of this Issue 11/2009

Diabetologia 11/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.